Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

Exit

PublicNASDAQ:FLXN
Raised
Post IPO Valuation

General Information

Websiteflexiontherapeuti...
Twitter@FlexionInc
CategoryBioTech
Phone781-897-9977
Employees
Founded2007

Offices

Woburn, USA
300 TradeCenter
Suite 2460
Woburn, MA, 01801
USA

People

Chief Executive Officer & Co-Founder
Chairman of the Board & Board of Director
Vice President, Finance and Administration
Vice President of CMC
Vice President of Quality
Vice President, Preclinical Research and Development
Vice President of Clinical Operations and Program Management
Board of Directors
Show All People

Funding

TOTAL $107M
FUNDING TOTAL $42M
Series A, 10/2009
Versant Ventures
5AM Ventures
Sofinnova Partners
$33M
Series A, 1/2010
Pfizer Venture Investments
$9M
POST IPO FUNDING TOTAL $65M
Post IPO Equity, 2/2014
$65M

Tags

Flexion Therapeutics

Flexion Therapeutics advances drug candidates through clinical proof of concept and beyond, in partnership with pharmaceutical and biotechnology companies. By providing expertise and sharing risk, Flexion effectively expands the portfolios of its partners.

Recent Milestones

Videos

Screenshots

Flexion Therapeutics screenshot
Above: Home Page
Uploaded: 1/20/10

Stock Price

Sources

  1. Flexion garners $33M in Series A (fiercebiotech.com) [edit]
  2. Flexion Therapeutics Closes $42M Series A Funding and Three in-licensing Deals (finsmes.com) [edit]
  3. Sofinnova Partners’ portfolio company Flexion Therapeutics successfully raises $65M (€47.6M) in its IPO (sofinnova.fr) [edit]
  4. Pain-Therapy Company Flexion Therapeutics Files for Nasdaq IPO (pevc.dowjones.com) [edit]
    Flexion files for $86.25 million in IPO financing (bioportfolio.com) [edit]
Edit This Page
Last Edited 2/12/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy